bluebird bio Income Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	552,704	555,394	544,393
Revenue Growth (YoY)	-	2.02%	-
Cost of Revenue	525,037	528,058	514,759
Gross Profit	27,667	27,335	29,634
Selling, General & Admin	20,634	20,573	18,307
Operating Expenses	20,634	20,573	18,307
Operating Income	7,032	6,763	11,327
Interest Expense	-6,392	-6,413	-8,905
Interest & Investment Income	2,617	2,617	1,902
Currency Exchange Gain (Loss)	-2,745	-2,311	-1,908
Other Non Operating Income (Expenses)	290.92	391.51	-87.36
EBT Excluding Unusual Items	802.99	1,048	2,329
Gain (Loss) on Sale of Assets	-	-	-340.59
Pretax Income	802.99	1,048	1,989
Income Tax Expense	-	-	66.02
Net Income	802.99	1,048	1,923
Net Income to Common	802.99	1,048	1,923
Net Income Growth	-	-45.48%	-
Shares Outstanding (Basic)	31	32	32
Shares Outstanding (Diluted)	31	32	32
EPS (Basic)	25.98	32.92	60.38
EPS (Diluted)	25.98	32.92	60.00
EPS Growth	-	-45.14%	-
Free Cash Flow	-56,259	-39,948	28,038
Free Cash Flow Per Share	-1820.45	-1254.52	880.50
Gross Margin	5.01%	4.92%	5.44%
Operating Margin	1.27%	1.22%	2.08%
Profit Margin	0.14%	0.19%	0.35%
Free Cash Flow Margin	-10.18%	-7.19%	5.15%
EBITDA	14,814	15,054	21,720
EBITDA Margin	2.68%	2.71%	3.99%
D&A For EBITDA	7,782	8,291	10,393
EBIT	7,032	6,763	11,327
EBIT Margin	1.27%	1.22%	2.08%
Effective Tax Rate	-	-	3.32%
Revenue as Reported	552,704	555,394	544,393

Source: S&P Global Market Intelligence. Standard template. Financial Sources.